Understand what the evidence says.
A molecule, a formulation and a finished product are different things. Use these short explanations to read ingredient research with the right context, then follow the source for the full detail.
01 The Details
What do two or three receptor targets mean?
Receptor terminology describes molecular activity. It does not rank products by safety, quality or suitability.
Tirzepatide: The cited pharmacology identifies activity at GIP and GLP-1 receptors.
Retatrutide: The cited trial describes activity at GIP, GLP-1 and glucagon receptors.
These references explain the named ingredients. They do not establish equivalence, approved use or clinical results for Peptides in Bali pens.
Read the tirzepatide pharmacology
Read the Retatrutide phase 2 study
Return to the product rangeA coenzyme and a peptide have different identities.
NAD+ is a coenzyme involved in cellular redox reactions. MOTS-c is described in the original research as a mitochondrial-derived peptide. Their connection to cell biology does not make them interchangeable.
The MOTS-c paper includes laboratory and mouse experiments. Neither a biochemical role nor preclinical research establishes a benefit from a Peptides in Bali pen in people.
Read the original MOTS-c research
Explore the NAD+ listingA medical indication has boundaries.
The cited US Tesamorelin label concerns excess abdominal fat in adults with HIV-associated lipodystrophy. It explicitly excludes general weight-loss management. Its indication applies to that specified formulation, not to the Peptides in Bali 32 mg pen.
Read the formulation-specific Tesamorelin label
View Tesamorelin product details02 Your Next Step
The product needs its own documentation.
A product photograph shows packaging. A batch document should identify the exact product and batch it covers. A reference to a study is a third kind of information. Read each for what it can establish.
Batch-specific testing, sterility, registration and current storage documentation have not been confirmed for these listings. Product pages identify the details that still need confirmation.
Prepare your product questionsGo to the source.
Read the original material behind the ingredient and safety notes. US and Australian regulatory references describe their own jurisdictions; they do not establish registration in Indonesia.
Tirzepatide ingredient pharmacology
Retatrutide phase 2 clinical study
FDA information on unapproved GLP-1 products
FDA safety context for compounded peptides
Tesamorelin indication and formulation limits
TGA context on melanotan and UV protection
Continue in KnowledgeFind Your Product
Explore all products, choose your format and review your cart.